Announcing 2022 Impact Factor for Acta Pharmaceutica Sinica B

导出

摘要 Acta Pharmaceutica Sinica B(APSB)is delighted to announce that the 2022 Impact Factor(IF)of the journal is now 14.5(13.8 without self-citations)according to the latest Clarivate Journal Citation Reports released on Jun 28th,2023.APSB ranks No.5(Q1 quartile)of the 277 journals in the Pharmacology and Pharmacy category.

出处《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2023年第12期I0002-I0002,共1页 药学学报（英文版）

关键词 JOURNAL PHARMACY IMPACT

分类号 Z88 [文化科学]

引文网络
相关文献

1Lei Yang,Xiao Chen,Kai-YueWang,Zhuang Liang,Li-Yun He.Research status of persistent vegetative state in recent 20 years:A bibliometric analysis[J].Life Research,2022,5(4):48-53.
2C.Richard Conti,MD,MACC.Some thoughts about Impact Factor and Journal Editorials[J].Cardiovascular Innovations and Applications,2017(B05):399-401.
3Announcing 2022 Impact Factor for Acta Pharmaceutica Sinica B[J].Acta Pharmaceutica Sinica B,2023,13(10).
4Editor Note[J].Chinese Chemical Letters,2023,34(1):588-588.
5Chee Kai CHUA.Cell powered biobots and more perspectives for IJB[J].International Journal of Bioprinting,2017,3(1):1-2.
6稀土文摘快报[J].稀土信息,2023(11):40-42.
7Acta Geologica Sinica (English Edition) Calls for Submission of Review Papers[J].Acta Geologica Sinica(English Edition),2023,97(6):1836-1836.
8Orthopaedic Surgery已被SCI和MEDLINE收录[J].中华骨科杂志,2023,43(23).
9科技论文写作小知识——影响因子[J].爆破,2023,40(4):141-141.
10Christopher Thomas Zoppo,Trenton Taros,Aaron Harman.Top 50 most cited articles on prostatic artery embolization for benign prostatic hyperplasia:A bibliometric review[J].World Journal of Clinical Urology,2023,12(1):1-9.

Acta Pharmaceutica Sinica B

2023年第12期

浏览历史

内容加载中请稍等...

Announcing 2022 Impact Factor for Acta Pharmaceutica Sinica B

相关作者

相关机构

相关主题

浏览历史